NASDAQ:PTLA - Portola Pharmaceuticals Price Target & Analyst Ratings

$28.90
+0.01 (+0.03 %)
(As of 08/22/2019 08:00 AM ET)
Today's Range
$28.41
Now: $28.90
$29.23
50-Day Range
$24.37
MA: $27.36
$31.10
52-Week Range
$14.81
Now: $28.90
$37.95
Volume927,000 shs
Average Volume1.53 million shs
Market Capitalization$1.97 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.18

Analyst Ratings

Portola Pharmaceuticals (NASDAQ:PTLA) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
6 Wall Street analysts have issued ratings and price targets for Portola Pharmaceuticals in the last 12 months. Their average twelve-month price target is $40.20, suggesting that the stock has a possible upside of 39.10%. The high price target for PTLA is $45.00 and the low price target for PTLA is $35.00. There are currently 2 hold ratings and 4 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.672.712.712.67
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $40.20$39.20$39.20$35.50
Price Target Upside: 39.10% upside46.65% upside28.27% upside23.22% upside

Portola Pharmaceuticals (NASDAQ:PTLA) Consensus Price Target History

Portola Pharmaceuticals (NASDAQ:PTLA) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/9/2019Morgan StanleySet Price TargetHold$37.00MediumView Rating Details
8/9/2019William BlairReiterated RatingBuyLowView Rating Details
8/8/2019CowenReiterated RatingBuy$45.00HighView Rating Details
8/5/2019Credit Suisse GroupReiterated RatingNeutral ➝ Neutral$35.00HighView Rating Details
4/12/2019OppenheimerSet Price TargetBuy$42.00LowView Rating Details
3/4/2019BNP ParibasBoost Price TargetOutperform ➝ Positive$30.00 ➝ $42.00HighView Rating Details
8/10/2018CitigroupLower Price TargetBuy ➝ Buy$64.00 ➝ $50.00N/AView Rating Details
12/1/2017Goldman Sachs GroupInitiated CoverageBuy ➝ Buy$75.00HighView Rating Details
(Data available from 8/22/2017 forward)
This page was last updated on 8/22/2019 by MarketBeat.com Staff

Featured Article: Leveraged Buyout (LBO)

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel